P04.13: Newborn affected by maternal use of anticonvulsants
P04.13 is a billable, specific ICD-10-CM code for newborn affected by maternal use of anticonvulsants. It is valid for submission on a claim.
Check P04.13 with the rest of the claim: free scrubberExcludes1 inherited from the categories above P04.13
A category’s note binds every code beneath it.
Excludes2 inherited from the categories above P04.13
Not part of this code, but both may be coded when both are present.
Written on P04.1: Newborn affected by other maternal medication
Written on P04: Newborn affected by noxious substances transmitted via placenta or breast milk
- congenital malformations (Q00-Q99)
- encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
- neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
- newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
Risk adjustment
P04.13 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 137 Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications0.424 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Alphabetic index entries that lead here
- Newborn›affected by›maternal›anticonvulsants
Code history
Unchanged in every release from FY2024 to FY2027.
Other codes under P04.1
- P04.11Newborn affected by maternal antineoplastic chemotherapy
- P04.12Newborn affected by maternal cytotoxic drugs
- P04.14Newborn affected by maternal use of opiates
- P04.15Newborn affected by maternal use of antidepressants
- P04.16Newborn affected by maternal use of amphetamines
- P04.17Newborn affected by maternal use of sedative-hypnotics
- P04.1ANewborn affected by maternal use of anxiolytics
- P04.18Newborn affected by other maternal medication
- P04.19Newborn affected by maternal use of unspecified medication